A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Clinical trial NCT02915159 · COMPLETED

Trial details

NCT number: NCT02915159
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sjogrens Disease

Start date: 2016-12-06
Primary completion: 2018-08-07
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.